Cellular and molecular pharmacology of auranofin and related gold complexes
Stanley T. Crooke(Stanley Foundation), Christopher K. Mirabelli(Upsher-Smith Laboratories (United Kingdom)), Rosanne M. Snyder(University of Pennsylvania), David J. Ecker(University of Colorado Denver), Tauseef R. Butt(Progenra (United States)), Brett P. Monia(Ionis Pharmaceuticals (United States)), H.S. Allaudeen(Upsher-Smith Laboratories (United Kingdom))
Cited by 49
Related Papers
miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting
|Cell Metabolism|2006|2.1k
PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients
|Cancer Cell|2004|1.9k
A Multiubiquitin Chain Is Confined to Specific Lysine in a Targeted Short-Lived Protein
|Science|1989|1.5k
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|1.4k